TransMedics Group (TMDX) Misses Q2 EPS by 6c, Revenues Beat; Raises FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel rattle AI trade
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil prices set for fourth straight monthly gains as tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts TMDX Hot Sheet
Join SI Premium – FREE
TransMedics Group (NASDAQ: TMDX) reported Q2 EPS of ($0.41), $0.06 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $20.5 million versus the consensus estimate of $16.2 million.
GUIDANCE:
TransMedics Group raises FY2022 revenue to $67-75 million, versus the consensus of $66.97 million.
For earnings history and earnings-related data on TransMedics Group (TMDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel on FedEx Freight (FDXF): 'Enters Its Post-Breakup Era - Time to Hit the Gym and Focus on Itself'
- Capri Holdings Limited (CPRI) Tops Q2 EPS by 21c; offers guidance
- Arbor Realty Trust (ABR) Misses Q3 EPS by 8c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
